FindTrial
Sign In

Genetic and Clinical study of Idiopathic Growth Hormone Deficiency (GHD).

Genotype, Phenotype and Radiological Correlation of Idiopathic Growth Hormone Deficiency (GHD) - GHD study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/01/003279
Enrollment
400
Registered
2013-01-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients diagnosed to have Idiopathic growth hormone deficiency.

Interventions

None listed

Sponsors

Diamond Jubilee Society Trust
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with 1.Height less than -3 SD for age and sex, and/or growth velocity 2.Failure of GH stimulation by Clonidine Test and/or Insulin Tolerance Test (ITT) (stimulated peak GH

Exclusion criteria

Exclusion criteria: Patient with growth hormone deficiency due to 1. Pituitary surgery 2. Radiotherapy 3. Sellar or suprasellar tumors 4. Infiltrative /inflammatory disorders 5. Trauma 6. Systemic Illness

Design outcomes

Primary

MeasureTime frame
Genotype-phenotype correlation for Idiopathic GHD patients through identification of germline mutations in Indian population to aid in better diagnosis and patient care.Timepoint: 5 years—

Secondary

MeasureTime frame
A practical and cost-effective flow-chart for genetic testing, counseling & patient management.Timepoint: 5 years—

Countries

India

Contacts

Public ContactDr Nalini S Shah

Seth G.S. Medical College, K.E.M

svk82004@gmail.com02224162917

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026